Keywords: Bone, Diffusion/other diffusion imaging techniques, RESOLVE DWI; multi-b-values-fitting; axial spondyloarthritis; quantitative; tumour necrosis factor inhibitors
Motivation: Methods to quantitatively assess disease activity and efficacy of axSpA are still being explored.
Goal(s): To find a reliable quantitative indicator for evaluating disease activity and curative effect of axSpA, using multi-b-values-fitting RESOLVE DWI.
Approach: By comparing the ADC values calculated by fitting different b values between different groups, a relatively reliable b-values-fitting sequence was obtained, further evaluating curative effect of the treatment group in different cycles.
Results: Multi-b-values-fitting (b=50,500,700s/mm2) RESOLVE DWI has a certain advantage in evaluating disease activity and efficacy of axSpA, but the effect of short-term review (3 weeks or less) is unsatisfactory.
Impact: Multi-b-Values-Fitting RESOLVE DWI can differentiate the severity of axSpA disease activity more intuitively, by measuring the ADC values of bone marrow edema of sacroiliac joints, providing a new idea for clinical search for more objective and accurate quantitative parameters.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords